Citation Impact
Citing Papers
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
2012 Standout
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression
2021 StandoutNobel
Stem Cell–Derived Culture Models of Hepatitis E Virus Infection
2018 StandoutNobel
Cytokines in inflammatory bowel disease
2014 Standout
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
2020 Standout
Enhancing extracellular vesicle cargo loading and functional delivery by engineering protein-lipid interactions
2024 StandoutNobel
Role of endoscopy in predicting the disease course in inflammatory bowel disease
2010
Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease
2015
Conventional Medical Management of Inflammatory Bowel Disease
2011
Formulation and Delivery Technologies for mRNA Vaccines
2020
Lipid nanoparticles for mRNA delivery
2021 Standout
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
A guide to immunometabolism for immunologists
2016 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus
2020 StandoutNobel
Crohn's disease
2012 Standout
Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer
2016 Standout
Biomarkers in Search of Precision Medicine in IBD
2016
Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration
2018
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
Astrocyte alterations in neurodegenerative pathologies and their modeling in human induced pluripotent stem cell platforms
2019
Protein Transfer Into Human Cells by VSV-G-induced Nanovesicles
2011
Mucosal healing with methotrexate in Crohn’s disease: a prospective comparative study with azathioprine and infliximab
2011
Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease: an update
2012
Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission?
2014
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Crohn's disease
2016 Standout
Chronic inflammatory diseases: Do immunological patterns drive the choice of biotechnology drugs? A critical review
2014
Results of the 2nd part Scientific Workshop of the ECCO (II): Measures and markers of prediction to achieve, detect, and monitor intestinal healing in Inflammatory Bowel Disease
2011
Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation
2015
Development and Validation of the Mucosal Inflammation Noninvasive Index For Pediatric Crohn’s Disease
2019
Chlorcyclizine Inhibits Viral Fusion of Hepatitis C Virus Entry by Directly Targeting HCV Envelope Glycoprotein 1
2020 StandoutNobel
Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease
2016
Accuracies of Serum and Fecal S100 Proteins (Calprotectin and Calgranulin C) to Predict the Response to TNF Antagonists in Patients with Crohnʼs Disease
2014
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Ulcerative colitis
2016 Standout
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
2015 StandoutNobel
Predictors of Infliximab Failure After Azathioprine Withdrawal in Crohn's Disease Treated With Combination Therapy
2010
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Optimizing anti-TNF treatments in inflammatory bowel disease
2013
Biomarkers of Inflammation in Inflammatory Bowel Disease
2015
Ulcerative colitis
2020 Standout
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
2019 Standout
Longitudinal study of circulating protein biomarkers in inflammatory bowel disease
2014
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
2014 Standout
Taming a beast: lessons from the domestication of hepatitis C virus
2019 StandoutNobel
Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid Protein
2017
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Functional expression and characterization of the envelope glycoprotein E1E2 heterodimer of hepatitis C virus
2019 StandoutNobel
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
Stem cell-derived polarized hepatocytes
2020 StandoutNobel
Rewiring cellular networks by members of the Flaviviridae family
2018
Systematic review: monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD
2014
Endoplasmic Reticulum Detergent-Resistant Membranes Accommodate Hepatitis C Virus Proteins for Viral Assembly
2019
Raised faecal calprotectin is associated with subsequent symptomatic relapse, in children and adolescents with inflammatory bowel disease in clinical remission
2017
Anti-TNF Therapy in Crohn’s Disease
2018
Systematic review with meta‐analysis: mucosal healing is associated with improved long‐term outcomes in Crohn's disease
2015
Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practice
2018
Computational Prediction of the Heterodimeric and Higher-Order Structure of gpE1/gpE2 Envelope Glycoproteins Encoded by Hepatitis C Virus
2017 StandoutNobel
Entry and Release of Hepatitis C Virus in Polarized Human Hepatocytes
2017
Comprehensive Meta-Analysis of COVID-19 Global Metabolomics Datasets
2021
Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis
2019 Standout
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
The Controversial Role of Human Gut Lachnospiraceae
2020 Standout
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
2013 StandoutNobel
Results from the 2nd Scientific Workshop of the ECCO (I): Impact of mucosal healing on the course of inflammatory bowel disease
2011
Depth of remission in Crohn's disease patients seen in a referral centre : associated factors and impact on disease outcome.
2014
Molecular diagnosis and classification of inflammatory bowel disease
2018
Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti‐TNF therapy
2015
The Influence of Probiotics on the Firmicutes/Bacteroidetes Ratio in the Treatment of Obesity and Inflammatory Bowel disease
2020 Standout
MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights
2021 Standout
Works of Éric Piver being referenced
Ultrastructural organisation of HCV from the bloodstream of infected patients revealed by electron microscopy after specific immunocapture
2016
Disruption of TCA Cycle and Glutamate Metabolism Identified by Metabolomics in an In Vitro Model of Amyotrophic Lateral Sclerosis
2015
The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism
2020
Serum calprotectin as a biomarker for Crohn's disease
2013
Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
2011
P274 Close monitoring of CRP and fecal calprotectin levels to predict relapse in Crohn's disease patients. A sub-analysis of the STORI study
2012
864 Close Monitoring of CRP and Fecal Calprotectin is Able to Predict Clinical Relapse in Patients With Crohn's Disease in Remission After Infliximab Withdrawal. a Sub-Analysis of the Stori Study
2012
Semliki Forest virus-derived virus-like particles: characterization of their production and transduction pathways
2005
Vesicular stomatitis virus glycoprotein: a transducing coat for SFV‐based RNA vectors
2004
Iron Metabolism Disturbance in a French Cohort of ALS Patients
2014
961 Infliximab Discontinuation in Crohn's Disease Patients in Stable Remission On Combined Therapy with Immunosuppressors: A Prospective Ongoing Cohort Study
2009